Equinom
PrivateLast Round
Series D
Dec 12, 2022
Total Funding Raised
$71.47M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Equinom operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Series D round in December 2022.
Equinom is an agrifood-tech company that develops non-GMO seeds and AI-powered grain optimization software to improve the nutritional and functional quality of plant-based food ingredients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Equinom Comparables
Compare Equinom with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Amfora Inc. | 79% | |
| NuCicer | 77% | |
| Pairwise | 76% |
For institutional investors. Book with your work email.
Equinom Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Dec 12, 2022 | ||||
| Series C | Jun 22, 2021 | ||||
| Series B | Feb 19, 2020 | ||||
| Grant | Jan 1, 2020 | ||||
| Grant | Aug 31, 2019 | ||||
VC Round | Oct 17, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Equinom Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bunge Ventures | Series D |
| Synthesis Capital | Series D |
| Maverick Ventures Israel | Series C |
| CPT Capital | Series D |
| The Phoenix Holdings Ltd. | Series C |
| Praesidium | Series D |
| Hazera Seeds | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors grew 370% MoM, reaching 771.
- Jun 19, 2026
Monthly visitors grew 66% MoM, reaching 956.
For institutional investors. Book with your work email.
Equinom Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Equinom's valuation, stock price, and market status.
Is Equinom a public or private company?
Equinom is a private company.
What is the current stock price of Equinom?
Equinom is a private company, so its shares have no public market price. Caplight tracks Equinom's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Equinom worth (valuation)?
Valuation information for Equinom is not publicly available.
Can I buy Equinom stock?
Equinom shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Equinom's last funding round?
Equinom's most recent funding round was Series D on December 12, 2022.
Who are the main investors in Equinom?
Key investors in Equinom include Synthesis Capital, The Phoenix Holdings Ltd., Hazera Seeds, BASF Venture Capital, Fortissimo Capital.
Will Equinom IPO soon?
No public IPO plans have been announced for Equinom.
How can I track Equinom secondary market activity?
Caplight tracks bids, offers, and trades in Equinom's shares on secondary markets.